Guizhou Yibai Pharmaceutical Co Ltd
600594
Company Profile
Business description
Guizhou Yibai Pharmaceutical Co Ltd engages in the research, development, production, and sale of pharmaceutical products in China. Its products include tumor, cardio-cerebral vascular, respiratory system, anti-rheumatic, digestive system, pediatric, gynecological, andrological, anti-infection, anti-inflammatory, analgesic, tonic, and other drugs.
Contact
No. 220-1 Baiyun Avenue
GuiyangGuizhou550008
CHNT: +86 85147055908223
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 December 2026
Employees
5,261
Stocks News & Analysis
stocks
A top global stock to buy after a big change in its forecast
Undervalued by 24%, this wide-moat stock is a buy now.
stocks
Does the AI trade still have room to run?
Where Morningstar analysts see opportunities—and where they don’t.
stocks
More gas left in the tank for ASX highflyer
Shares jumped after results and are screening as overvalued.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,189.90 | 15.70 | 0.17% |
| CAC 40 | 8,131.15 | 11.90 | -0.15% |
| DAX 40 | 24,933.08 | 32.37 | 0.13% |
| Dow JONES (US) | 49,460.25 | 361.54 | 0.74% |
| FTSE 100 | 10,148.85 | 5.41 | 0.05% |
| HKSE | 26,765.52 | 135.56 | 0.51% |
| NASDAQ | 23,638.19 | 136.95 | 0.58% |
| Nikkei 225 | 52,885.25 | 803.64 | -1.50% |
| NZX 50 Index | 13,460.74 | 96.13 | -0.71% |
| S&P 500 | 6,959.97 | 44.36 | 0.64% |
| S&P/ASX 200 | 8,860.10 | 15.00 | 0.17% |
| SSE Composite Index | 4,132.60 | 3.56 | -0.09% |